United Therapeutics (UTHR) Finished Goods (2010 - 2020)

United Therapeutics (UTHR) has 11 years of Finished Goods data on file, last reported at $43.8 million in Q1 2020.

• For the quarter ending Q1 2020, Finished Goods fell 7.98% year-over-year to $43.8 million; the trailing twelve-month figure through Mar 2020 stood at $43.8 million (down 7.98% YoY), and the FY2019 full-year result was $43.2 million, down 11.29% from the prior year.
• Finished Goods advanced to $43.8 million in Q1 2020, from $43.2 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $62.2 million in Q3 2017 to a low of $37.3 million in Q2 2016.
• A 5-year average of $48.9 million and a median of $48.7 million in 2018 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods jumped 65.15% in 2017 and fell 20.58% in 2018, its largest moves.
• Tracing UTHR's Finished Goods over 5 years: stood at $49.7 million in 2016, then rose by 12.47% to $55.9 million in 2017, then fell by 12.88% to $48.7 million in 2018, then slipped by 11.29% to $43.2 million in 2019, then increased by 1.39% to $43.8 million in 2020.
• Business Quant data shows UTHR's Finished Goods at $43.8 million in Q1 2020, $43.2 million in Q4 2019, and $45.0 million in Q3 2019.